Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

November 27, 2019
The Right Time for Portugal-Born Pharma Projects to Step-Up to…
The Portuguese pharma industry has developed into a market of national and international products… Read More
November 25, 2019
Analytical Methods for the Investigation of Carcinogenic Nitrosamines in APIs…
Learn more about the analytical methods which can be utilised for the testing of… Read More
November 11, 2019
Three Steps Towards Fulfilling the EMA Nitrosamine Advice
How a results-driven, chemistry-based strategy will enable companies to meet MAH responsibilities with the… Read More
More Articles

UPCOMING Events

All Events
Contact Us